- Research works
- 3 fractional, all time
- Citations
- 18 6.7 per fractional work
- Top-10% rate
- 100.0% record average 16.5%
- Open access
- 12% world 28%
Not ranked overall: Aesculapius Farmaceutici (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Aesculapius Farmaceutici (Italy) publish most on?
By volume in 2022–2025: Effects and risks of endocrine disrupting chemicals and Microplastics and Plastic Pollution.
- 1 Effects and risks of endocrine disrupting chemicals Health, Toxicology and Mutagenesis 0 works
- 2 Microplastics and Plastic Pollution Pollution 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
openly available12.5%not open87.5%
World: 28% of research is openly available.
with international co-authors12.5%domestic only87.5%
World: 19% is written across borders.
How has Aesculapius Farmaceutici (Italy)'s research output changed?
Other research institutions in Brescia
- University of Brescia
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna "Bruno Ubertini"
- Centro San Giovanni di Dio Fatebenefratelli
- Fondazione Poliambulanza Istituto Ospedaliero
- Gruppo di Ricerca Geriatrica
- Ospedale Sant'Orsola di Brescia
- Lucchini (Italy)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.